All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.
Bookmark this article
During a meeting of the Lymphoma Hub Steering Committee, Giles Salles chaired a discussion in which the steering committee debated how to treat high-risk follicular lymphoma. This included a discussion on how newly diagnosed high-risk follicular lymphoma should be treated, the impact of relapsed/refractory disease, and the standard of care.
How to treat high-risk follicular lymphoma.
Understanding your specialty helps us to deliver the most relevant and engaging content.
Please spare a moment to share yours.
Please select or type your specialty
Mayo Clinic Lymphoma eTumor Board | Follicular lymphoma
This case study discusses the presentation and management of a patient with de novo follicular lymphoma.
Mayo Clinic Lymphoma eTumor Board | In situ follicular neoplasia in two anatomical sites
This case study discusses the presentation and management of a patient with in situ follicular neoplasia in two distinct anatomical sites.
Subscribe to get the best content related to lymphoma & CLL delivered to your inbox